Effects of postnatal dexamethasone exposure on the developmental outcome of premature infants

Howard William Needelman, Martha Evans, Holly Jean Roberts, Matthew Sweney, J. B. Bodensteiner

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Extremely low birth weight premature infants are at risk for poor neurodevelopmental outcome. Postnatal dexamethasone has often been used in premature infants to prevent or treat bronchopulmonary dysplasia, and this drug is thought by some to affect neurodevelopmental outcome. We retrospectively examined the effect of this steroid on early neurodevelopment. Dexamethasone exposure was associated with an adverse outcome and was a stronger predictor of outcome than other accepted risk factors. If used, dexamethasone should be used in these high-risk infants for as short a period as possible.

Original languageEnglish (US)
Pages (from-to)421-424
Number of pages4
JournalJournal of Child Neurology
Volume23
Issue number4
DOIs
StatePublished - Apr 1 2008

Fingerprint

Premature Infants
Dexamethasone
Extremely Low Birth Weight Infant
Bronchopulmonary Dysplasia
Steroids
Pharmaceutical Preparations

Keywords

  • Developmental outcome
  • Dexamethasone
  • Premature infant

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

Effects of postnatal dexamethasone exposure on the developmental outcome of premature infants. / Needelman, Howard William; Evans, Martha; Roberts, Holly Jean; Sweney, Matthew; Bodensteiner, J. B.

In: Journal of Child Neurology, Vol. 23, No. 4, 01.04.2008, p. 421-424.

Research output: Contribution to journalArticle

@article{e570fbf594fd459eadc870d23f1b9054,
title = "Effects of postnatal dexamethasone exposure on the developmental outcome of premature infants",
abstract = "Extremely low birth weight premature infants are at risk for poor neurodevelopmental outcome. Postnatal dexamethasone has often been used in premature infants to prevent or treat bronchopulmonary dysplasia, and this drug is thought by some to affect neurodevelopmental outcome. We retrospectively examined the effect of this steroid on early neurodevelopment. Dexamethasone exposure was associated with an adverse outcome and was a stronger predictor of outcome than other accepted risk factors. If used, dexamethasone should be used in these high-risk infants for as short a period as possible.",
keywords = "Developmental outcome, Dexamethasone, Premature infant",
author = "Needelman, {Howard William} and Martha Evans and Roberts, {Holly Jean} and Matthew Sweney and Bodensteiner, {J. B.}",
year = "2008",
month = "4",
day = "1",
doi = "10.1177/0883073807309232",
language = "English (US)",
volume = "23",
pages = "421--424",
journal = "Journal of Child Neurology",
issn = "0883-0738",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Effects of postnatal dexamethasone exposure on the developmental outcome of premature infants

AU - Needelman, Howard William

AU - Evans, Martha

AU - Roberts, Holly Jean

AU - Sweney, Matthew

AU - Bodensteiner, J. B.

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Extremely low birth weight premature infants are at risk for poor neurodevelopmental outcome. Postnatal dexamethasone has often been used in premature infants to prevent or treat bronchopulmonary dysplasia, and this drug is thought by some to affect neurodevelopmental outcome. We retrospectively examined the effect of this steroid on early neurodevelopment. Dexamethasone exposure was associated with an adverse outcome and was a stronger predictor of outcome than other accepted risk factors. If used, dexamethasone should be used in these high-risk infants for as short a period as possible.

AB - Extremely low birth weight premature infants are at risk for poor neurodevelopmental outcome. Postnatal dexamethasone has often been used in premature infants to prevent or treat bronchopulmonary dysplasia, and this drug is thought by some to affect neurodevelopmental outcome. We retrospectively examined the effect of this steroid on early neurodevelopment. Dexamethasone exposure was associated with an adverse outcome and was a stronger predictor of outcome than other accepted risk factors. If used, dexamethasone should be used in these high-risk infants for as short a period as possible.

KW - Developmental outcome

KW - Dexamethasone

KW - Premature infant

UR - http://www.scopus.com/inward/record.url?scp=41549146265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41549146265&partnerID=8YFLogxK

U2 - 10.1177/0883073807309232

DO - 10.1177/0883073807309232

M3 - Article

C2 - 18079310

AN - SCOPUS:41549146265

VL - 23

SP - 421

EP - 424

JO - Journal of Child Neurology

JF - Journal of Child Neurology

SN - 0883-0738

IS - 4

ER -